Female surgeon creates revolutionary OTC productGail Lebovic’s recent move in health care came in 2020, with the formation of Silicon Valley Innovations, and its OTC flagship product, NasoClenz. Vanda provides update to Hetlioz ANDA litigation appealThe United States Court of Appeals for the Federal Circuit has granted a motion to temporarily enjoin the generic launch by Teva and Apotex of Hetlioz. Parexel partners with MyEyeDr. to increase patient participation in ophthalmology clinical trials The new collaboration leverages MyEyeDr.’s 850+ offices to refer patients into ophthalmology clinical trials. N.J. judge finds Bausch Health spin-off not imminent A New Jersey judge has ordered Bausch Health to provide advance notice of intent to spin in order to allow injunction challenge. Patients deserve access to safe, affordable pharmacy services Lynne Fruth, president and chairman of Fruth Pharmacy, shares her insights on the current state of the pharmacy business. ANI intros generic Carnitor Generic Carnitor is used for the treatment of primary systemic carnitine deficiency. CSL Behring obtains FDA OK for Hemgenix Hemgenix is the first gene therapy to treat adults with Hemophilia B. Yaral Pharma launches in the U.S. Yaral Pharma will begin commercializing the first product from IBSA’s corporate pipeline of authorized generics in January 2023. Sun Pharma gains FDA OK for Sezaby Sezaby is the first and only product approved for treating seizures in neonatal patients. Eagle receives FDA nod for new indication for Pemfexy The additional indication is for the initial treatment of patients with metastatic, non-squamous, non-small cell lung cancer with no EGFR or ALK genomic tumor aberrations. First Previous 117 118 119 120 121 Next Last
